Preprint · OA
via OpenAlex
Senescent Cell Clearance Ameliorates Temporal Lobe Epilepsy and Associated Spatial Memory Deficits in Mice
Tahiyana Khan, David J. McFall, Abbas I. Hussain, Logan A. Frayser, Timothy P. Casilli, Meaghan C. Steck, Irene Sánchez-Brualla, Noah M. Kuehn, Michelle Cho, Jacqueline A. Barnes, Brent T. Harris, Stefano Vicini, Patrick Alexander Forcelli
Annals of Neurology · 2025 · ▲ 5 citations
Abstract
OBJECTIVE: The pharmacological treatment of temporal lobe epilepsy (TLE), a disorder characterized by recurrent seizures and cognitive dysfunction, is limited to symptomatic control. Identifying novel targets to modify disease progression is of great clinical and translational interest. Cellular senescence(definition) has been recently implicated in the development and progression of other neurodegenerative diseases, but its role in TLE is unstudied. METHODS: We first investigated cellular senescence markers in resected hippocampi from patients with medically intractable TLE through multiplexed immunofluorescence. We next used a mouse model of TLE (pilocarpine induced status epilepticus [SE]) for a combination of immunohistochemistry, behavioral testing, and electroencephalogram (EEG) monitoring. We implemented 2 strategies for removal of senescent cells (SCs), a genetic mouse model allowing for targeted senolysis, and a pharmacological approach using dasatinib and quercetin. RESULTS: We found a 5-fold elevation of senescent glia in human TLE cases as compared with controls. In mice, we found increases in senescence markers at both the transcript and protein level and predominantly expressed in microglia, which developed within 2 weeks following SE. Senolytic treatment produced a 50% reduction in SCs, rescued long-term potentiation deficits, normalized spatial memory impairments, reduced seizures, and protected a third of animals from epilepsy. INTERPRETATION: Our data demonstrate that SCs accumulate in both human TLE and in a mouse model of TLE and suggest that clearing SCs may be a viable strategy to reduce seizures and associated cognitive comorbidities. ANN NEUROL 2026;99:1059-1075.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1002/ana.78118
- Canonical
- link ↗
- Fetched
- 2026-11-11 MST
Cite this
APA
Khan, T., McFall, D.J., Hussain, A.I., Frayser, L.A., Casilli, T.P., Steck, M.C., Sánchez-Brualla, I., Kuehn, N.M., Cho, M., Barnes, J.A., Harris, B.T., Vicini, S., & Forcelli, P.A. (2025). Senescent Cell Clearance Ameliorates Temporal Lobe Epilepsy and Associated Spatial Memory Deficits in Mice. <em>Annals of Neurology</em>. https://doi.org/10.1002/ana.78118
Vancouver
Khan T, McFall DJ, Hussain AI, Frayser LA, Casilli TP, Steck MC, et al. Senescent Cell Clearance Ameliorates Temporal Lobe Epilepsy and Associated Spatial Memory Deficits in Mice. Annals of Neurology. 2025. doi:10.1002/ana.78118.
BibTeX
@unpublished{tahiyana2025Senesc,
title = {Senescent Cell Clearance Ameliorates Temporal Lobe Epilepsy and Associated Spatial Memory Deficits in Mice},
author = {Tahiyana Khan and David J. McFall and Abbas I. Hussain and Logan A. Frayser and Timothy P. Casilli and Meaghan C. Steck and Irene Sánchez-Brualla and Noah M. Kuehn and Michelle Cho and Jacqueline A. Barnes and Brent T. Harris and Stefano Vicini and Patrick Alexander Forcelli},
journal = {Annals of Neurology},
year = {2025},
doi = {10.1002/ana.78118},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) 2021
Preprint · OA
Effect of senolytic anti-aging compounds in Down syndrome-driven senescence
The FASEB Journal 2020
Citation only
The senolytic drug fisetin mitigates age‐related bone density loss in the progeroid mouse model Zmpste24 −/−
Journal of Alzheimer s Disease 2024
Preprint · OA
Senescence Targeting Methods Impact Alzheimer’s Disease Features in 3xTg Mice
International Journal of Molecular Sciences 2024
Open access · CC-BY
Partial Reprogramming Exerts a Rejuvenating Effect on Human Mesenchymal Stem Cells That Underwent Replicative Senescence in Culture
International journal of molecular sciences 2024
Open access · OA
Partial Reprogramming Exerts a Rejuvenating Effect on Human Mesenchymal Stem Cells That Underwent Replicative Senescence in Culture.
Expert Reviews in Molecular Medicine 2023
Open access · CC-BY